Dashboard
1
The company has declared positive results for the last 6 consecutive quarters
- PRE-TAX PROFIT(Q) At CNY 38.49 MM has Grown at 271.77%
- NET PROFIT(Q) At CNY 20.2 MM has Grown at 231.48%
- ROCE(HY) Highest at 7.06%
2
With ROE of 7.74%, it has a attractive valuation with a 2.99 Price to Book Value
Stock DNA
Tour, Travel Related Services
CNY 3,133 Million (Small Cap)
39.00
NA
0.00%
-0.45
9.42%
2.77
Revenue and Profits:
Net Sales:
240 Million
(Quarterly Results - Mar 2026)
Net Profit:
36 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
26.25%
0%
26.25%
6 Months
12.12%
0%
12.12%
1 Year
89.37%
0%
89.37%
2 Years
36.65%
0%
36.65%
3 Years
45.32%
0%
45.32%
4 Years
52.22%
0%
52.22%
5 Years
90.12%
0%
90.12%
Youngy Health Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.28%
EBIT Growth (5y)
18.52%
EBIT to Interest (avg)
33.28
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.60
Tax Ratio
25.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.86%
ROE (avg)
5.32%
Valuation key factors
Factor
Value
P/E Ratio
39
Industry P/E
Price to Book Value
2.99
EV to EBIT
27.43
EV to EBITDA
21.32
EV to Capital Employed
6.72
EV to Sales
3.31
PEG Ratio
0.37
Dividend Yield
NA
ROCE (Latest)
24.49%
ROE (Latest)
7.74%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
239.90
251.60
-4.65%
Operating Profit (PBDIT) excl Other Income
49.00
56.70
-13.58%
Interest
0.00
0.00
Exceptional Items
1.70
1.50
13.33%
Consolidate Net Profit
36.40
43.00
-15.35%
Operating Profit Margin (Excl OI)
204.20%
201.30%
0.29%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -4.65% vs 42.71% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -15.35% vs 52.48% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
932.30
688.10
35.49%
Operating Profit (PBDIT) excl Other Income
164.50
91.70
79.39%
Interest
2.20
1.00
120.00%
Exceptional Items
2.10
5.70
-63.16%
Consolidate Net Profit
108.10
66.10
63.54%
Operating Profit Margin (Excl OI)
146.60%
91.30%
5.53%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 35.49% vs 30.12% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 63.54% vs 57.76% in Dec 2024
About Youngy Health Co., Ltd. 
Youngy Health Co., Ltd.
Tour, Travel Related Services
No Details Available.
Company Coordinates 
No Company Details Available






